These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10562305)

  • 41. Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children.
    Scott-Algara D; Buseyne F; Porrot F; Corre B; Bellal N; Rouzioux C; Blanche S; Riviere Y
    J Clin Immunol; 2005 Jan; 25(1):57-67. PubMed ID: 15742158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients.
    Silvestris F; Camarda G; Del Prete A; Tucci M; Dammacco F
    Eur J Clin Invest; 1999 Nov; 29(11):980-91. PubMed ID: 10583444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.
    Rutebemberwa A; Currier JR; Jagodzinski L; McCutchan F; Birx D; Marovich M; Cox JH
    AIDS; 2005 Jul; 19(11):1165-72. PubMed ID: 15990569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
    Thomas AS; Jones KL; Gandhi RT; McMahon DK; Cyktor JC; Chan D; Huang SH; Truong R; Bosque A; Macedo AB; Kovacs C; Benko E; Eron JJ; Bosch RJ; Lalama CM; Simmens S; Walker BD; Mellors JW; Jones RB
    PLoS Pathog; 2017 Sep; 13(9):e1006629. PubMed ID: 28931091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women.
    Lohman BL; Slyker J; Mbori-Ngacha D; Bosire R; Farquhar C; Obimbo E; Otieno P; Nduati R; Rowland-Jones S; John-Stewart G
    J Infect Dis; 2003 Dec; 188(11):1666-74. PubMed ID: 14639537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD8 T cell response to Nef peptides and HIV type 1 control in early-treated patients after antiretroviral treatment interruption.
    Poccia F; Gioia C; Corpolongo A; D'Offizi G; Narcisco P; Martini F
    AIDS Res Hum Retroviruses; 2006 Apr; 22(4):330-2. PubMed ID: 16623635
    [No Abstract]   [Full Text] [Related]  

  • 47. A systematic comparison of methods to measure HIV-1 specific CD8 T cells.
    Sun Y; Iglesias E; Samri A; Kamkamidze G; Decoville T; Carcelain G; Autran B
    J Immunol Methods; 2003 Jan; 272(1-2):23-34. PubMed ID: 12505709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
    SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
    J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients.
    Dalod M; Sinet M; Deschemin JC; Fiorentino S; Venet A; Guillet JG
    Eur J Immunol; 1999 Jan; 29(1):38-44. PubMed ID: 9933084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.
    Riou C; Burgers WA; Mlisana K; Koup RA; Roederer M; Abdool Karim SS; Williamson C; Gray CM
    J Virol; 2014 Feb; 88(3):1819-24. PubMed ID: 24227857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS.
    Kostense S; Vandenberghe K; Joling J; Van Baarle D; Nanlohy N; Manting E; Miedema F
    Blood; 2002 Apr; 99(7):2505-11. PubMed ID: 11895786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk.
    Sabbaj S; Edwards BH; Ghosh MK; Semrau K; Cheelo S; Thea DM; Kuhn L; Ritter GD; Mulligan MJ; Goepfert PA; Aldrovandi GM
    J Virol; 2002 Aug; 76(15):7365-73. PubMed ID: 12097549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire.
    Jennes W; Vuylsteke B; Borget MY; Traore-Ettiegne V; Maurice C; Nolan M; Nkengasong JN; Kestens L
    J Infect Dis; 2004 Feb; 189(4):602-10. PubMed ID: 14767812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-specific IL-10-positive CD8+ T cells suppress cytolysis and IL-2 production by CD8+ T cells.
    Elrefaei M; Ventura FL; Baker CA; Clark R; Bangsberg DR; Cao H
    J Immunol; 2007 Mar; 178(5):3265-71. PubMed ID: 17312176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The significance of western blot assays indeterminate for antibody to HIV in a cohort of homosexual/bisexual men. The Multicenter AIDS Cohort Study.
    Phair J; Hoover D; Huprikar J; Detels R; Kaslow R; Rinaldo C; Saah A
    J Acquir Immune Defic Syndr (1988); 1992 Oct; 5(10):988-92. PubMed ID: 1453328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.
    Cheingsong-Popov R; Panagiotidi C; Ali M; Bowcock S; Watkins P; Aronstam A; Wassef M; Weber J
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1099-105. PubMed ID: 2265027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Ranki A; Järvinen K; Valle SL; Nurmilaakso P; Krohn K
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):348-55. PubMed ID: 2179525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.
    Mackewicz CE; Yang LC; Lifson JD; Levy JA
    Lancet; 1994 Dec; 344(8938):1671-3. PubMed ID: 7996961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon.
    Gupta SB; Mast CT; Wolfe ND; Novitsky V; Dubey SA; Kallas EG; Schechter M; Mbewe B; Vardas E; Pitisuttithum P; Burke D; Freed D; Mogg R; Coplan PM; Condra JH; Long RS; Anderson K; Casimiro DR; Shiver JW; Straus WL
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):135-9. PubMed ID: 16760794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.